These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 29548654)
21. A case of meningoencephalitis associated with macrolide-resistant Mycoplasma pneumoniae infection. Koga S; Ishiwada N; Honda Y; Okunushi T; Hishiki H; Ouchi K; Kohno Y Pediatr Int; 2012 Oct; 54(5):724-6. PubMed ID: 23005909 [TBL] [Abstract][Full Text] [Related]
22. Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for Mycoplasma pneumoniae pneumonia. Kawamata R; Yokoyama K; Sato M; Goto M; Nozaki Y; Takagi T; Kumagai H; Yamagata T J Infect Chemother; 2015 Nov; 21(11):783-9. PubMed ID: 26298038 [TBL] [Abstract][Full Text] [Related]
23. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Lee KY; Lee HS; Hong JH; Lee MH; Lee JS; Burgner D; Lee BC Pediatr Pulmonol; 2006 Mar; 41(3):263-8. PubMed ID: 16437541 [TBL] [Abstract][Full Text] [Related]
24. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China]. Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430 [TBL] [Abstract][Full Text] [Related]
25. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. Miyashita N; Maruyama T; Kobayashi T; Kobayashi H; Taguchi O; Kawai Y; Yamaguchi T; Ouchi K; Oka M J Infect Chemother; 2011 Feb; 17(1):114-8. PubMed ID: 20676912 [TBL] [Abstract][Full Text] [Related]
26. Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides. Nilsson AC; Jensen JS; Björkman P; Persson K Scand J Infect Dis; 2014 Apr; 46(4):315-9. PubMed ID: 24447251 [TBL] [Abstract][Full Text] [Related]
28. [Critical analysis of antibiotic therapy of acute respiratory infections caused by Mycoplasma pneumoniae]. Kuzman I; Petricević I Plucne Bolesti; 1989; 41(1-2):13-7. PubMed ID: 2508137 [TBL] [Abstract][Full Text] [Related]
29. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2. Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857 [TBL] [Abstract][Full Text] [Related]
30. Adjunct Systemic Corticosteroid Therapy in Children With Community-Acquired Pneumonia in the Outpatient Setting. Ambroggio L; Test M; Metlay JP; Graf TR; Blosky MA; Macaluso M; Shah SS J Pediatric Infect Dis Soc; 2015 Mar; 4(1):21-7. PubMed ID: 26407353 [TBL] [Abstract][Full Text] [Related]
31. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland. Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315 [No Abstract] [Full Text] [Related]
33. Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia. Atkinson TP; Boppana S; Theos A; Clements LS; Xiao L; Waites K Pediatrics; 2011 Jun; 127(6):e1605-9. PubMed ID: 21536614 [TBL] [Abstract][Full Text] [Related]
34. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan. Wu PS; Chang LY; Lin HC; Chi H; Hsieh YC; Huang YC; Liu CC; Huang YC; Huang LM Pediatr Pulmonol; 2013 Sep; 48(9):904-11. PubMed ID: 23169584 [TBL] [Abstract][Full Text] [Related]
35. Mycoplasma pneumoniae detection causes excess antibiotic use in Norwegian general practice: a retrospective case-control study. Foshaug M; Vandbakk-Rüther M; Skaare D; Grude N; Lindbæk M Br J Gen Pract; 2015 Feb; 65(631):e82-8. PubMed ID: 25624311 [TBL] [Abstract][Full Text] [Related]
36. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. Kogoj R; Mrvic T; Praprotnik M; Kese D Euro Surveill; 2015; 20(37):. PubMed ID: 26536357 [TBL] [Abstract][Full Text] [Related]
37. [Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna]. Kurz H; Göpfrich H Wien Med Wochenschr; 2011 Apr; 161(7-8):180-3. PubMed ID: 20963506 [TBL] [Abstract][Full Text] [Related]
38. Surveillance of Mycoplasma pneumoniae infection among children in Beijing from 2007 to 2012. Zhao H; Li S; Cao L; Yuan Y; Xue G; Feng Y; Yan C; Wang L; Fan Z; Sun H Chin Med J (Engl); 2014; 127(7):1244-8. PubMed ID: 24709174 [TBL] [Abstract][Full Text] [Related]
39. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood]. Ouchi K Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086 [TBL] [Abstract][Full Text] [Related]
40. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China. Ma Z; Zheng Y; Deng J; Ma X; Liu H Pediatr Pulmonol; 2014 Jul; 49(7):695-700. PubMed ID: 23861188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]